NanoMedical Systems, Inc.


NanoMedical Systems develops innovative drug-delivery devices based on its proprietary nStrada™ nanofluidics platform, aiming to provide sustained and controlled release of therapies through subcutaneous implants. Their mission is to improve drug delivery performance significantly over traditional polymer-based implants, utilizing advanced nanotechnology and scalable manufacturing processes.

Industries

biotechnology
medical
nanotechnology
therapeutics

Nr. of Employees

small (1-50)

NanoMedical Systems, Inc.

Austin, Texas, United States, North America


Products

Nanochannel-based subcutaneous implant platform

An implantable reservoir system that uses precision nanochannels to provide tunable, constant release of therapeutic agents (small molecules, peptides, proteins) over weeks to more than a year without power or moving parts.


Services

Prototype and volume fabrication of nanochannel chips

Production of nano-fluidic chips using semiconductor fabrication methods aimed at high yield and reproducibility for implantable drug-delivery devices.

Preclinical evaluation of implant delivery performance

In vitro and in vivo testing to demonstrate sustained-release performance and pharmacokinetics across multiple animal models.

Expertise Areas

  • Implantable sustained-release drug delivery
  • Nanofluidics for controlled release
  • Semiconductor-based medical device manufacturing
  • Biocompatible materials and coating development
  • Show More (3)

Key Technologies

  • Nanochannel-based passive diffusion delivery
  • Semiconductor micro/nanofabrication
  • High-density nanochannel arrays
  • Biocompatible coatings and nano-structures
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.